Literature DB >> 29070665

Blood-brain barrier leakage increases with small vessel disease in acute ischemic stroke.

Francesco Arba1, Richard Leigh2, Domenico Inzitari2, Steven J Warach2, Marie Luby2, Kennedy R Lees2.   

Abstract

OBJECTIVE: In patients with acute ischemic stroke, we aimed to investigate the relation between preexisting small vessel disease (SVD) and the amount of blood-brain barrier (BBB) leakage in ischemic and nonischemic area before IV thrombolysis.
METHODS: We retrospectively accessed anonymous patient-level data from the Stroke Imaging Repository and the Virtual International Stroke Trials Archive resources and included patients treated with IV thrombolysis with pretreatment MRI. We rated SVD features using validated qualitative magnetic resonance (MR) scales. Leakage of BBB was assessed with postprocessing of perfusion-weighted images. We evaluated associations between SVD features (individually and summed in a global SVD score) and BBB leakage using linear regression analysis, adjusting for major clinical confounders.
RESULTS: A total of 212 patients, mean age (±SD) 69.5 years (±16.1), 102 (48%) male, had available MR before IV thrombolysis. Evidence of BBB leakage was present in 175 (80%) and 205 (94%) patients in the ischemic and nonischemic area, respectively. Lacunar infarcts (β = 0.17, p = 0.042) were associated with BBB leakage in the ischemic area, and brain atrophy was associated with BBB leakage in both ischemic (β = 0.20, p = 0.026) and nonischemic (β = 0.27, p = 0.001) areas. Increasing SVD grade was independently associated with BBB leakage in both ischemic (β = 0.26, p = 0.007) and nonischemic (β = 0.27, p = 0.003) area.
CONCLUSIONS: Global SVD burden is associated with increased BBB leakage in both acutely ischemic and nonischemic area. Our results support that SVD score has construct validity, and confirm a relation between SVD and BBB disruption also in patients with acute stroke.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 29070665      PMCID: PMC5696647          DOI: 10.1212/WNL.0000000000004677

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Recombinant tissue plasminogen activator increases blood-brain barrier disruption in acute ischemic stroke: an MR imaging permeability study.

Authors:  A Kassner; T P L Roberts; B Moran; F L Silver; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-06       Impact factor: 3.825

2.  Screening with MRI for Accurate and Rapid Stroke Treatment: SMART.

Authors:  Shreyansh Shah; Marie Luby; Karen Poole; Teresa Morella; Elizabeth Keller; Richard T Benson; John K Lynch; Zurab Nadareishvili; Amie W Hsia
Journal:  Neurology       Date:  2015-05-13       Impact factor: 9.910

Review 3.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

Review 4.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Authors:  Alida A Gouw; Alexandra Seewann; Wiesje M van der Flier; Frederik Barkhof; Annemieke M Rozemuller; Philip Scheltens; Jeroen J G Geurts
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

5.  Early blood-brain barrier disruption in human focal brain ischemia.

Authors:  Lawrence L Latour; Dong-Wha Kang; Mustapha A Ezzeddine; Julio A Chalela; Steven Warach
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

6.  Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.

Authors:  Alexis N Simpkins; Christian Dias; Richard Leigh
Journal:  Stroke       Date:  2016-07-26       Impact factor: 7.914

7.  Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.

Authors:  Richard Leigh; Shyian S Jen; Argye E Hillis; John W Krakauer; Peter B Barker
Journal:  Stroke       Date:  2014-05-15       Impact factor: 7.914

8.  Analysis of three leakage-correction methods for DSC-based measurement of relative cerebral blood volume with respect to heterogeneity in human gliomas.

Authors:  Anne Kluge; Mathias Lukas; Vivien Toth; Thomas Pyka; Claus Zimmer; Christine Preibisch
Journal:  Magn Reson Imaging       Date:  2015-12-17       Impact factor: 2.546

9.  Pretreatment blood-brain barrier disruption and post-endovascular intracranial hemorrhage.

Authors:  Richard Leigh; Søren Christensen; Bruce C V Campbell; Michael P Marks; Gregory W Albers; Maarten G Lansberg
Journal:  Neurology       Date:  2016-06-17       Impact factor: 9.910

10.  Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden.

Authors:  Julie Staals; Stephen D J Makin; Fergus N Doubal; Martin S Dennis; Joanna M Wardlaw
Journal:  Neurology       Date:  2014-08-27       Impact factor: 9.910

View more
  29 in total

1.  Post-Stroke Blood-Brain Barrier Disruption and Poor Functional Outcome in Patients Receiving Thrombolytic Therapy.

Authors:  Zurab Nadareishvili; Alexis N Simpkins; Emi Hitomi; Dennys Reyes; Richard Leigh
Journal:  Cerebrovasc Dis       Date:  2019-04-10       Impact factor: 2.762

2.  Small Vessel Disease Is Associated with Tissue Inhibitor of Matrix Metalloproteinase-4 After Ischaemic Stroke.

Authors:  Francesco Arba; Benedetta Piccardi; Vanessa Palumbo; Betti Giusti; Patrizia Nencini; Anna Maria Gori; Alice Sereni; Mascia Nesi; Giovanni Pracucci; Giorgio Bono; Paolo Bovi; Enrico Fainardi; Domenico Consoli; Antonia Nucera; Francesca Massaro; Giovanni Orlandi; Francesco Perini; Rossana Tassi; Maria Sessa; Danilo Toni; Rosanna Abbate; Domenico Inzitari
Journal:  Transl Stroke Res       Date:  2018-04-23       Impact factor: 6.829

3.  Global changes in diffusion tensor imaging during acute ischemic stroke and post-stroke cognitive performance.

Authors:  Kyle C Kern; Clinton B Wright; Richard Leigh
Journal:  J Cereb Blood Flow Metab       Date:  2022-05-17       Impact factor: 6.960

4.  Effect of Cerebral Small Vessel Disease Burden on Outcomes in Patients With Acute Ischemic Stroke Receiving Endovascular Treatment.

Authors:  Hao Huang; Weifeng Zong; Xu Tong; Xue Tian; Anxin Wang; Baixue Jia; Jing Zhao; Lingshan Wu; Xirui Zhou; Yinping Guo; Yi Zhang; Zhiyuan Yu; Yilong Wang; Yongjun Wang; Xiang Luo; Zhongrong Miao
Journal:  Front Aging Neurosci       Date:  2022-06-13       Impact factor: 5.702

Review 5.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

Review 6.  Conversion of upbeat to downbeat nystagmus in Wernicke encephalopathy.

Authors:  Jorge C Kattah; Ali Saber Tehrani; Sascha du Lac; David E Newman-Toker; David S Zee
Journal:  Neurology       Date:  2018-10-23       Impact factor: 9.910

7.  White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors.

Authors:  Nidhi Gupta; Alexis N Simpkins; Emi Hitomi; Christian Dias; Richard Leigh
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-10-31       Impact factor: 2.136

8.  Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke.

Authors:  Francesco Arba; Alessio Giannini; Benedetta Piccardi; Silvia Biagini; Vanessa Palumbo; Betti Giusti; Patrizia Nencini; Anna Maria Gori; Mascia Nesi; Giovanni Pracucci; Giorgio Bono; Paolo Bovi; Enrico Fainardi; Domenico Consoli; Antonia Nucera; Francesca Massaro; Giovanni Orlandi; Francesco Perini; Rossana Tassi; Maria Sessa; Danilo Toni; Rosanna Abbate; Domenico Inzitari
Journal:  Eur Stroke J       Date:  2018-10-22

9.  Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease.

Authors:  Marlies P Noz; Annemieke Ter Telgte; Kim Wiegertjes; Anil M Tuladhar; Charlotte Kaffa; Simone Kersten; Siroon Bekkering; Charlotte D C C van der Heijden; Alexander Hoischen; Leo A B Joosten; Mihai G Netea; Marco Duering; Frank-Erik de Leeuw; Niels P Riksen
Journal:  Front Cardiovasc Med       Date:  2021-05-13

10.  MTT and Blood-Brain Barrier Disruption within Asymptomatic Vascular WM Lesions.

Authors:  B E Dewey; X Xu; L Knutsson; A Jog; J L Prince; P B Barker; P C M van Zijl; R Leigh; P Nyquist
Journal:  AJNR Am J Neuroradiol       Date:  2021-06-03       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.